Bacillus Calmette–Guerin (BCG) intravesical instillation therapy is the most effective adjuvant therapy for bladder cancer after transurethral resection of bladder tumor. However, Bacillus Calmette–Guerin therapy is associated with a high risk o...
Non‐muscle‐invasive bladder cancerSince the turn of the 20th century Bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer (NMIBC) has been in and out of favour. However, only a small proportion of patients, as low as 16%, complete what is seen as a gold ...
About 4 to 6 hours after treatment, you may have bladder symptoms such as sudden urges to urinate, frequent urination, stomach discomfort, bloating, and possibly loss of bladder control. Tell your doctor right away if these side effects last for longer than 2 or 3 days. ...
Intravesical bacillus Calmette-Guerin (BCG) has been established as an effective treatment of superficial bladder cancer (Parker and Kommu, 2013). However, major side effects, including pneumonitis, sepsis, and even death, may occur in <5% of patients (Gonzalez et al., 2003). Here we present...
Immunotherapy for Bladder Cancer Initiate treatment 7-14 days after the biopsy TheraCys: Instill one dose into the bladder; retain for 2 hr; repeat dose once weekly for 6 weeks followed by 1 treatment at 3, 6, 12, 18, and 24 months after initial treatment ...
-a treatment that controlssuperficial bladder cancer, particularlycarcinoma in situ. I was surprised tolearn that an ancient vaccine, originallydesigned to prevent tuberculosis (TB), isemployed for a completely unrelatedindication and is the current treatment ofchoice for bladder cancer. I thought that...
Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment Cancer immunotherapy has rapidly become the fourth mainstream treatment alternative after surgery, radiotherapy, and chemotherapy, with some promising resu... S Zeng,S Xing,Y Zhang,... - Journal of Zhejiang University-SC...
BCG Aortic aneurysm Aorto-enteric fistula Bladder carcinoma 1. Introduction Intravesical BCG is increasingly used as an adjunct therapy in the treatment of transitional cell carcinoma of the bladder.1 The procedure is generally considered safe but side-effects, most commonly fever and malaise, occur....
Abstract Importance The BCG vaccine—used worldwide to prevent tuberculosis—confers multiple nonspecific beneficial effects, and intravesical BCG vaccine is currently the recommended treatment for non–muscle-invasive bladder cancer (NMIBC). Moreover, BCG vaccine has been hypothesized to reduce the risk ...
BCG is a potent immunomodulator, especially of the cell-mediated immunity, and is employed for the treatment of cancers such as that of the bladder30. It is actually being tested for several other cancers31. Recently, BCG was shown to exhibit efficacy against type I diabetes32. This was ...